Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Versha

Showing results (161-170 of 186) with videos related to

Pageof 19
Sort By:
Trials|December 23, 2017
Promoting deceased organ and tissue donation registration in family physician waiting rooms (RegisterNow-1 trial): study protocol for a pragmatic, stepped-wedge, cluster randomized controlled registryAlvin H Li, Amit X Garg, Versha Prakash, et al.
Pilot and Feasibility Studies|February 23, 2023
Protocol for a pilot randomised controlled trial to evaluate integrated support from pharmacist independent prescriber and third sector worker for people experiencing homelessness: the PHOENIx community pharmacy studyVibhu Paudyal, Richard Lowrie, Frances S Mair, et al.
Health Technology Assessment (Winchester, England)|September 11, 2024
Preventing recurrence of endometriosis-related pain by means of long-acting progestogen therapy: the PRE-EMPT RCTKevin G Cooper, Siladitya Bhattacharya, Jane P Daniels, et al.
Cancers|March 15, 2020
Mitochondrial Respiration Correlates with Prognostic Markers in Chronic Lymphocytic Leukemia and Is Normalized by Ibrutinib TreatmentSubir Roy Chowdhury, Eric D J Bouchard, Ryan Saleh, et al.
The Journal of Clinical Investigation|February 14, 2012
The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemiaVersha Banerji, Stacey M Frumm, Kenneth N Ross, et al.
The Journal of Experimental Medicine|June 22, 2016
Targeting MTHFD2 in acute myeloid leukemiaYana Pikman, Alexandre Puissant, Gabriela Alexe, et al.
British Journal of Haematology|June 1, 2021
Patient-reported fatigue refines prognosis in higher-risk myelodysplastic syndromes (MDS): a MDS-CAN studyIrina Amitai, Michelle Geddes, Nancy Zhu, et al.
Haematologica|August 18, 2022
High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromesJennifer Teichman, Michelle Geddes, Nancy Zhu, et al.
BMC Medicine|March 3, 2022
Promoting deceased organ and tissue donation registration in family physician waiting rooms (RegisterNow-1): a pragmatic stepped-wedge, cluster randomized controlled registry trialAlvin Ho-Ting Li, Amit X Garg, Jeremy M Grimshaw, et al.
Journal of Geriatric Oncology|June 17, 2026
Patient-reported outcomes in BRUIN CLL-321: A randomized phase 3 trial comparing pirtobrutinib to investigators choice of idelalisib plus rituximab or bendamustine plus rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma in the post-cBTKi settingPaolo Ghia, Davide Rossi, Emmanuelle Ferrant, et al.
Pageof 19

Showing results (161-170 of 186) with videos related to

Sort By:
Pageof 19
Trials|December 23, 2017
Promoting deceased organ and tissue donation registration in family physician waiting rooms (RegisterNow-1 trial): study protocol for a pragmatic, stepped-wedge, cluster randomized controlled registryAlvin H Li, Amit X Garg, Versha Prakash, et al.
Pilot and Feasibility Studies|February 23, 2023
Protocol for a pilot randomised controlled trial to evaluate integrated support from pharmacist independent prescriber and third sector worker for people experiencing homelessness: the PHOENIx community pharmacy studyVibhu Paudyal, Richard Lowrie, Frances S Mair, et al.
Health Technology Assessment (Winchester, England)|September 11, 2024
Preventing recurrence of endometriosis-related pain by means of long-acting progestogen therapy: the PRE-EMPT RCTKevin G Cooper, Siladitya Bhattacharya, Jane P Daniels, et al.
Cancers|March 15, 2020
Mitochondrial Respiration Correlates with Prognostic Markers in Chronic Lymphocytic Leukemia and Is Normalized by Ibrutinib TreatmentSubir Roy Chowdhury, Eric D J Bouchard, Ryan Saleh, et al.
The Journal of Clinical Investigation|February 14, 2012
The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemiaVersha Banerji, Stacey M Frumm, Kenneth N Ross, et al.
The Journal of Experimental Medicine|June 22, 2016
Targeting MTHFD2 in acute myeloid leukemiaYana Pikman, Alexandre Puissant, Gabriela Alexe, et al.
British Journal of Haematology|June 1, 2021
Patient-reported fatigue refines prognosis in higher-risk myelodysplastic syndromes (MDS): a MDS-CAN studyIrina Amitai, Michelle Geddes, Nancy Zhu, et al.
Haematologica|August 18, 2022
High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromesJennifer Teichman, Michelle Geddes, Nancy Zhu, et al.
BMC Medicine|March 3, 2022
Promoting deceased organ and tissue donation registration in family physician waiting rooms (RegisterNow-1): a pragmatic stepped-wedge, cluster randomized controlled registry trialAlvin Ho-Ting Li, Amit X Garg, Jeremy M Grimshaw, et al.
Journal of Geriatric Oncology|June 17, 2026
Patient-reported outcomes in BRUIN CLL-321: A randomized phase 3 trial comparing pirtobrutinib to investigators choice of idelalisib plus rituximab or bendamustine plus rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma in the post-cBTKi settingPaolo Ghia, Davide Rossi, Emmanuelle Ferrant, et al.
Pageof 19